Phytosterolaemia associated with parenteral nutrition administration in adult patients.
Adult
Cholesterol
/ analogs & derivatives
Fat Emulsions, Intravenous
/ analysis
Female
Fish Oils
/ analysis
Humans
Hypercholesterolemia
/ etiology
Inpatients
Intestinal Diseases
/ etiology
Lipid Metabolism, Inborn Errors
/ etiology
Male
Parenteral Nutrition
/ adverse effects
Parenteral Nutrition Solutions
/ chemistry
Phytosterols
/ adverse effects
Plant Oils
/ analysis
Prospective Studies
Stigmasterol
/ analysis
Vegetables
/ chemistry
Intravenous fat emulsions
Parenteral nutrition
Phytosterols
Journal
The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547
Informations de publication
Date de publication:
28 06 2020
28 06 2020
Historique:
pubmed:
23
2
2020
medline:
17
2
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
Vegetable lipid emulsions (LE) contain non-declared phytosterols (PS). We aimed to determine PS content depending on the brand and LE batch, and in adult hospitalised patients treated with parenteral nutrition (PN), to establish the association between plasma and administered PS. Part I was the LE study: totals and fractions of PS in three to four non-consecutive batches from six LE were analysed. Part II was the patient study: patients with at least 7 previous days of PN with 0·8 g/kg per d of an olive/soyabean (O/S) LE were randomised (day 0) 1:1 to O/S or 100 % fish oil (FO) at a dose of 0·4 g/kg per d for 7 d (day 7). Plasma PS, its fractions, total cholesterol on days 0 and 7, their clearance and their association with PS administered by LE were studied. In part I, LE study: differences were found in the total PS, their fractions and cholesterol among different LE brands and batches. Exclusive soyabean LE had the highest content of PS (422·36 (sd 130·46) μg/ml). In part II, patient study: nineteen patients were included. In the O/S group, PS levels were maintained (1·11 (sd 6·98) μg/ml) from day 0 to 7, while in the FO group, significant decreases were seen in total PS (-6·21 (sd 4·73) μg/ml) and their fractions, except for campesterol and stigmasterol. Plasma PS on day 7 were significantly associated with PS administered (R2 0·443). PS content in different LE brands had great variability. PS administered during PN resulted in accumulation and could be prevented with the exclusive administration of FO LE.
Identifiants
pubmed: 32077392
pii: S0007114520000574
doi: 10.1017/S0007114520000574
doi:
Substances chimiques
Fat Emulsions, Intravenous
0
Fish Oils
0
Parenteral Nutrition Solutions
0
Phytosterols
0
Plant Oils
0
campesterol
5L5O665639
Cholesterol
97C5T2UQ7J
Stigmasterol
99WUK5D0Y8
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM